UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

Constellation Pharmaceuticals, Inc.
(Name of Issuer)

Common Stock, par value $0.0001 per share
(Title of Class of Securities)

210373106
(CUSIP Number)

July 18, 2018
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
T Rule 13d-1(b)
£ Rule 13d-1(c)
£ Rule 13d-1(d)
*  The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
1
NAME OF REPORTING PERSONS
 
The Regents of the University of California
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
Not Applicable
(a)
(b)
 
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
California
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
 
2,297,406*
6
SHARED VOTING POWER
 
0
7
SOLE DISPOSITIVE POWER
 
2,297,406*
8
SHARED DISPOSITIVE POWER
 
0
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,297,406*
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
Not Applicable
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
8.9%
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
EP
 
 
*Shares beneficially owned as of July 25, 2018.
 
Item 1(a).
Name of Issuer:

Constellation Pharmaceuticals, Inc.

Item 1(b).
Address of Issuer's Principal Executive Offices:

215 First Street, Suite 200, Cambridge, Massachusetts  02142

Item 2(a).
Name of Person Filing:

The Regents of the University of California

Item 2(b).
Address of Principal Business Office or, if none, Residence:

1111 Broadway, 21st Floor, Oakland, CA  94607-4026

Item 2(c).
Citizenship:

The Regents of the University of California is a California non-profit corporation.

Item 2(d).
Title of Class of Securities:

Common Stock, par value $0.0001 per share

Item 2(e).
CUSIP Number:

None

Item 3.
If this statement is filed pursuant to sections 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

(f)
T  An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
 

Item 4.
Ownership:

(a)
Amount Beneficially Owned:  2,297,406*

(b)
Percent of Class:  8.9%

(c)
Number of shares as to which such person has:

(i)
sole power to vote or to direct the vote:  2,297,406*

(ii)
shared power to vote or to direct the vote:  0

(iii)
sole power to dispose or to direct the disposition of:  2,297,406*

(iv)
shared power to dispose or to direct the disposition of:  0
 
*Information as of July 25, 2018.
Item 5.
Ownership of Five Percent or Less of a Class:

Not applicable.

Item 6.
Ownership of More than Five Percent on Behalf of Another Person:

Not applicable.

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not applicable.

Item 8.
Identification and Classification of Members of the Group:

Not applicable.

Item 9.
Notice of Dissolution of Group:

Not applicable.
 

Item 10.
Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date:  July 25, 2018


The Regents of the University of California


By:  /s/ Jagdeep Singh Bachher  
Jagdeep Singh Bachher
Chief Investment Officer